Karyopharm Therapeutics Inc. (KPTI)
USD 3.66
(-5.18%)
USD 3.66
(-5.18%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 376.64 Million USD | 0.48% |
| 2022 | 374.82 Million USD | -2.64% |
| 2021 | 384.97 Million USD | 46.66% |
| 2020 | 262.5 Million USD | 7.06% |
| 2019 | 245.18 Million USD | 55.16% |
| 2018 | 158.02 Million USD | 210.88% |
| 2017 | 50.83 Million USD | 180.18% |
| 2016 | 18.14 Million USD | 6.23% |
| 2015 | 17.07 Million USD | 26.1% |
| 2014 | 13.54 Million USD | 311.39% |
| 2013 | 3.29 Million USD | -88.72% |
| 2012 | 29.18 Million USD | 46.86% |
| 2011 | 19.87 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 346.11 Million USD | -7.31% |
| 2024 Q3 | 349.12 Million USD | 0.87% |
| 2024 Q1 | 373.41 Million USD | -0.86% |
| 2023 Q1 | 370.97 Million USD | -1.03% |
| 2023 FY | 376.64 Million USD | 0.48% |
| 2023 Q2 | 369.07 Million USD | -0.51% |
| 2023 Q3 | 370.35 Million USD | 0.35% |
| 2023 Q4 | 376.64 Million USD | 1.7% |
| 2022 Q4 | 374.82 Million USD | 0.89% |
| 2022 FY | 374.82 Million USD | -2.64% |
| 2022 Q3 | 371.51 Million USD | -0.35% |
| 2022 Q2 | 372.81 Million USD | -1.14% |
| 2022 Q1 | 377.11 Million USD | -2.04% |
| 2021 Q1 | 314.54 Million USD | 19.83% |
| 2021 FY | 384.97 Million USD | 46.66% |
| 2021 Q4 | 384.97 Million USD | 1.29% |
| 2021 Q3 | 380.07 Million USD | 2.81% |
| 2021 Q2 | 369.69 Million USD | 17.53% |
| 2020 Q1 | 249.99 Million USD | 1.96% |
| 2020 FY | 262.5 Million USD | 7.06% |
| 2020 Q4 | 262.5 Million USD | 3.42% |
| 2020 Q3 | 253.81 Million USD | 1.44% |
| 2020 Q2 | 250.21 Million USD | 0.09% |
| 2019 Q2 | 155.63 Million USD | -6.21% |
| 2019 Q4 | 245.18 Million USD | 3.07% |
| 2019 FY | 245.18 Million USD | 55.16% |
| 2019 Q1 | 165.93 Million USD | 5.0% |
| 2019 Q3 | 237.87 Million USD | 52.85% |
| 2018 Q2 | 43.11 Million USD | -15.2% |
| 2018 FY | 158.02 Million USD | 210.88% |
| 2018 Q4 | 158.02 Million USD | 223.06% |
| 2018 Q3 | 48.91 Million USD | 13.44% |
| 2018 Q1 | 50.84 Million USD | 0.03% |
| 2017 Q1 | 17.07 Million USD | -5.9% |
| 2017 Q4 | 50.83 Million USD | 124.95% |
| 2017 FY | 50.83 Million USD | 180.18% |
| 2017 Q3 | 22.59 Million USD | 18.7% |
| 2017 Q2 | 19.03 Million USD | 11.5% |
| 2016 FY | 18.14 Million USD | 6.23% |
| 2016 Q3 | 16.69 Million USD | -3.69% |
| 2016 Q2 | 17.33 Million USD | 14.78% |
| 2016 Q4 | 18.14 Million USD | 8.69% |
| 2016 Q1 | 15.09 Million USD | -11.59% |
| 2015 Q4 | 17.07 Million USD | 4.27% |
| 2015 Q3 | 16.37 Million USD | 2.59% |
| 2015 Q2 | 15.96 Million USD | -3.32% |
| 2015 Q1 | 16.51 Million USD | 21.94% |
| 2015 FY | 17.07 Million USD | 26.1% |
| 2014 Q1 | 5.18 Million USD | 57.5% |
| 2014 FY | 13.54 Million USD | 311.39% |
| 2014 Q4 | 13.54 Million USD | 84.23% |
| 2014 Q3 | 7.35 Million USD | 22.54% |
| 2014 Q2 | 5.99 Million USD | 15.7% |
| 2013 Q1 | - USD | -100.0% |
| 2013 FY | 3.29 Million USD | -88.72% |
| 2013 Q3 | 103.68 Million USD | 3980.6% |
| 2013 Q4 | 3.29 Million USD | -96.83% |
| 2013 Q2 | 2.54 Million USD | 0.0% |
| 2012 FY | 29.18 Million USD | 46.86% |
| 2012 Q4 | 29.18 Million USD | 0.0% |
| 2011 FY | 19.87 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -12.171% |
| Alkermes plc | 933.53 Million USD | 59.654% |
| Agenus Inc. | 462.29 Million USD | 18.527% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 90.701% |
| Aptorum Group Limited | 5.25 Million USD | -7064.976% |
| Ardelyx, Inc. | 130.76 Million USD | -188.036% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 21.268% |
| Bicycle Therapeutics plc | 224.41 Million USD | -67.836% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -189.259% |
| ChromaDex Corporation | 26.5 Million USD | -1320.869% |
| Chimerix, Inc. | 19.74 Million USD | -1807.541% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -970.707% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -419.029% |
| CRISPR Therapeutics AG | 346.76 Million USD | -8.616% |
| Precision BioSciences, Inc. | 140.92 Million USD | -167.275% |
| Dyadic International, Inc. | 2.34 Million USD | -15991.421% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -2215.956% |
| Fortress Biotech, Inc. | 165.93 Million USD | -126.977% |
| Lantern Pharma Inc. | 2.73 Million USD | -13647.727% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -426.922% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -10573.657% |
| Incyte Corporation | 1.59 Billion USD | 76.345% |
| IO Biotech, Inc. | 17.55 Million USD | -2045.386% |
| Jaguar Health, Inc. | 45.86 Million USD | -721.183% |
| Novavax, Inc. | 2.57 Billion USD | 85.358% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -944.55% |
| Opthea Limited | 264.6 Million USD | -42.344% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -188.159% |
| ContextLogic Inc. | 206 Million USD | -82.837% |
| MiMedx Group, Inc. | 96.33 Million USD | -290.993% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -684.316% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -10573.167% |
| NextCure, Inc. | 14.99 Million USD | -2411.462% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -9218.258% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -5540.917% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -705.845% |
| Vaxcyte, Inc. | 167.44 Million USD | -124.931% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1032.453% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -60.128% |
| Pharming Group N.V. | 244.07 Million USD | -54.316% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -3059.235% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -194.734% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -5600.44% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -5600.44% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -356.909% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -5569.788% |
| Acelyrin, Inc. | 86.35 Million USD | -336.168% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -28889.541% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -2519.403% |
| Summit Therapeutics Inc. | 125.25 Million USD | -200.697% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -3873.457% |
| Senti Biosciences, Inc. | 52.57 Million USD | -616.448% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -447.631% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -148.59% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -19155.828% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -28101.12% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -66.045% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -3920.967% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -65.598% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 23.835% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -3351.017% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1269.067% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -3011.552% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 22.597% |
| Immix Biopharma, Inc. | 3.72 Million USD | -10019.988% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -896.096% |
| MEI Pharma, Inc. | 8.35 Million USD | -4408.007% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1198.101% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -8.362% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -158.207% |
| Fortress Biotech, Inc. | 165.93 Million USD | -126.977% |
| Precigen, Inc. | 41.64 Million USD | -804.438% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -654.344% |
| AlloVir, Inc. | 45.01 Million USD | -736.708% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -188.977% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -173.327% |
| ImmuCell Corporation | 18.81 Million USD | -1901.826% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1234.387% |
| Onconetix, Inc. | 23.18 Million USD | -1524.804% |
| PureTech Health plc | 125.58 Million USD | -199.916% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -4108.313% |
| Elevation Oncology, Inc. | 34.28 Million USD | -998.664% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -15304.663% |
| Seer, Inc. | 39.36 Million USD | -856.799% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -509.121% |
| Innoviva, Inc. | 568.55 Million USD | 33.754% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1283.297% |
| ESSA Pharma Inc. | 3.49 Million USD | -10676.433% |
| GlycoMimetics, Inc. | 6.9 Million USD | -5356.968% |
| GT Biopharma, Inc. | 6.63 Million USD | -5578.336% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -42.458% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -38.326% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -348.247% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -3753.53% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1286.301% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -11576.085% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -410.586% |
| Aptose Biosciences Inc. | 15.8 Million USD | -2282.511% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -3311.727% |
| Soligenix, Inc. | 7.27 Million USD | -5077.305% |
| Century Therapeutics, Inc. | 175.94 Million USD | -114.074% |
| Kura Oncology, Inc. | 51.66 Million USD | -629.054% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -210.552% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -9013.09% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -5594.773% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -49.108% |
| Autolus Therapeutics plc | 263.9 Million USD | -42.718% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -3493.246% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -323.857% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -703.096% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -6.742% |
| GRI Bio, Inc. | 2.69 Million USD | -13865.295% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -46423.095% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1111.425% |
| IGM Biosciences, Inc. | 220.17 Million USD | -71.064% |
| INmune Bio, Inc. | 18.86 Million USD | -1896.84% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -46.852% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1313.733% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -13755.326% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -11382.118% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -544.332% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -291.689% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -42.272% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 54.237% |
| Verastem, Inc. | 71.18 Million USD | -429.106% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -665.91% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -876.318% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -669.729% |
| Histogen Inc. | 5.69 Million USD | -6511.269% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -8488.188% |
| Surrozen, Inc. | 8.14 Million USD | -4524.236% |
| Organovo Holdings, Inc. | 2.74 Million USD | -13606.114% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -119904.588% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -569.829% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -2181.032% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -637.029% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -45450.295% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -197.214% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -3383.062% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -149.617% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -14345.499% |
| Apollomics, Inc. | 14.15 Million USD | -2561.231% |
| Amarin Corporation plc | 279.58 Million USD | -34.714% |
| Mesoblast Limited | 188.79 Million USD | -99.496% |
| Turnstone Biologics Corp. | 14.14 Million USD | -2562.171% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -108.335% |
| Synaptogenix, Inc. | 5.52 Million USD | -6711.576% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -5565.523% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -121.415% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -4301.49% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -21331.973% |
| Exelixis, Inc. | 678.44 Million USD | 44.484% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1479.75% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -129.597% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 36.614% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3426.562% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -23097.85% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -867.565% |
| Gritstone bio, Inc. | 125.91 Million USD | -199.116% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2466.394% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -7301.682% |
| Avid Bioservices, Inc. | 275.66 Million USD | -36.63% |
| Insmed Incorporated | 1.66 Billion USD | 77.335% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -4795.28% |
| MediWound Ltd. | 27.18 Million USD | -1285.383% |
| OmniAb, Inc. | 87.4 Million USD | -330.943% |
| Alector, Inc. | 487.66 Million USD | 22.766% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 6.646% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1944.201% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -881.534% |
| Zai Lab Limited | 240.17 Million USD | -56.819% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 40.221% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1188.685% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -296.146% |
| Immunic, Inc. | 25.36 Million USD | -1384.721% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -444.0% |
| Veracyte, Inc. | 93.71 Million USD | -301.886% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -14294.003% |
| FibroGen, Inc. | 585.72 Million USD | 35.696% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2066.738% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -57572.308% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -6559.832% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 95.081% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -4494.34% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -348.268% |
| TG Therapeutics, Inc. | 169.08 Million USD | -122.754% |
| Galecto, Inc. | 5.89 Million USD | -6288.128% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -4446.644% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 85.615% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1206.793% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -2884.264% |
| XBiotech Inc. | 8.39 Million USD | -4385.459% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2466.394% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -608.244% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -3.728% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1300.997% |
| Theravance Biopharma, Inc. | 169 Million USD | -122.861% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 69.016% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 24.735% |
| Vaxxinity, Inc. | 30.94 Million USD | -1117.179% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 61.27% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -6145.023% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 49.46% |
| NexImmune, Inc. | 5.08 Million USD | -7308.081% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -101313.593% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -12149.191% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 94.7% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -7207.757% |
| Scopus BioPharma Inc. | 7.45 Million USD | -4952.617% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1332.433% |
| Ainos, Inc. | 7.39 Million USD | -4993.76% |
| Pluri Inc. | 34.11 Million USD | -1004.139% |
| Prothena Corporation plc | 135.01 Million USD | -178.96% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -54.932% |
| Celularity Inc. | 102.92 Million USD | -265.926% |
| Rallybio Corporation | 9.43 Million USD | -3891.564% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1440.781% |
| MeiraGTx Holdings plc | 319.99 Million USD | -17.705% |
| Omeros Corporation | 403.25 Million USD | 6.598% |
| Humacyte, Inc. | 114.67 Million USD | -228.439% |
| Immunocore Holdings plc | 228.15 Million USD | -65.08% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -7626.031% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -390.805% |
| Blueprint Medicines Corporation | 918.64 Million USD | 59.0% |
| CalciMedica, Inc. | 4.02 Million USD | -9250.645% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -2058.171% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -144.347% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -338.892% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -35.584% |
| Pulmatrix, Inc. | 15.96 Million USD | -2259.481% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -2287.903% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1430.7% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -50.172% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -641.629% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 68.889% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1085.049% |
| Nutriband Inc. | 1.07 Million USD | -34809.386% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -3442.218% |
| Vor Biopharma Inc. | 59.1 Million USD | -537.256% |
| Roivant Sciences Ltd. | 773.95 Million USD | 51.335% |
| Evogene Ltd. | 17.99 Million USD | -1993.63% |
| ProKidney Corp. | 29.21 Million USD | -1189.17% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -423.269% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -53325.969% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 80.06% |
| CorMedix Inc. | 11.91 Million USD | -3060.421% |
| BioLineRx Ltd. | 50.7 Million USD | -642.858% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -152.005% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -325.87% |
| Atai Life Sciences N.V. | 49.16 Million USD | -666.128% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1109.041% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1996.893% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -202.195% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -6561.549% |
| MediciNova, Inc. | 3.89 Million USD | -9578.501% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1960.528% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -24938.807% |
| GeoVax Labs, Inc. | 3.51 Million USD | -10600.475% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 5.189% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1127.253% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 86.162% |
| Mereo BioPharma Group plc | 15.96 Million USD | -2259.629% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1107.154% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -541.817% |
| Absci Corporation | 58.3 Million USD | -546.0% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1877.341% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1074.736% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -410.427% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -330.534% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1015.321% |
| Allakos Inc. | 74.79 Million USD | -403.582% |
| Imunon, Inc. | 8.53 Million USD | -4315.301% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1573.899% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -228.053% |
| BioAtla, Inc. | 48.98 Million USD | -668.881% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3426.562% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -13453.221% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -188.386% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -2549.624% |
| XOMA Corporation | 145.58 Million USD | -158.72% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1018.8% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -447.774% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1092.025% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -509.23% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -737.638% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -678.158% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -13023.484% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -4516.857% |
| Akari Therapeutics, Plc | 4.58 Million USD | -8116.492% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2023.957% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 77.166% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -93149.948% |
| UroGen Pharma Ltd. | 243.52 Million USD | -54.665% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -17.303% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -13538.823% |
| Orgenesis Inc. | 35.53 Million USD | -959.924% |
| Entera Bio Ltd. | 1.37 Million USD | -27212.835% |
| GH Research PLC | 6.7 Million USD | -5520.713% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -5438.882% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1900.659% |
| Xencor, Inc. | 283.55 Million USD | -32.827% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -12515.037% |
| Replimune Group, Inc. | 113.21 Million USD | -232.683% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -9924.793% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -263.802% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -93149.948% |
| Portage Biotech Inc. | 4.45 Million USD | -8363.91% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -24938.807% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1534.03% |
| OncoCyte Corporation | 49.29 Million USD | -664.015% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -9004.708% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -47129.035% |
| Purple Biotech Ltd. | 10 Million USD | -3664.558% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -6409.575% |
| scPharmaceuticals Inc. | 57.26 Million USD | -557.767% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2940.389% |
| HilleVax, Inc. | 78.9 Million USD | -377.314% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -7358.297% |
| Tharimmune, Inc. | 1.81 Million USD | -20651.21% |
| Genprex, Inc. | 3.25 Million USD | -11474.06% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1288.857% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -7093.354% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -182736.893% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -104947.023% |
| OKYO Pharma Limited | 7.42 Million USD | -4975.486% |
| Savara Inc. | 37.19 Million USD | -912.702% |
| Curis, Inc. | 57.61 Million USD | -553.76% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1330.483% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -860.832% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -25983.38% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1709.136% |
| BeiGene, Ltd. | 2.23 Billion USD | 83.138% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1669.129% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -43.54% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1670.443% |
| Erasca, Inc. | 78.61 Million USD | -379.124% |
| bluebird bio, Inc. | 424.62 Million USD | 11.299% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -57380.786% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 80.072% |
| DBV Technologies S.A. | 42.8 Million USD | -780.009% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -57380.786% |
| Moderna, Inc. | 4.57 Billion USD | 91.762% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -5284.475% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -22644.203% |
| Molecular Templates, Inc. | 31.17 Million USD | -1108.315% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -2106.467% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 35.956% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -202.513% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1272.759% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -933.147% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -576.991% |
| MacroGenics, Inc. | 154.2 Million USD | -144.246% |
| RenovoRx, Inc. | 4.46 Million USD | -8333.587% |
| Adicet Bio, Inc. | 37.12 Million USD | -914.666% |
| Prime Medicine, Inc. | 60.78 Million USD | -519.684% |
| Aditxt, Inc. | 28.53 Million USD | -1220.096% |
| Adagene Inc. | 45.16 Million USD | -733.849% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -208334.928% |
| Quantum-Si incorporated | 26.63 Million USD | -1314.307% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 46.006% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -12279.677% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -227.628% |
| SciSparc Ltd. | 1.59 Million USD | -23514.044% |
| Vericel Corporation | 127.7 Million USD | -194.933% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -6668.215% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -341.252% |
| Generation Bio Co. | 171.63 Million USD | -119.451% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -3160.987% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -800.394% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -49.049% |
| Invivyd, Inc. | 51.71 Million USD | -628.335% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -309.498% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -5689.846% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -398.893% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -36789.716% |
| 2seventy bio, Inc. | 310.12 Million USD | -21.449% |
| ADMA Biologics, Inc. | 193.97 Million USD | -94.17% |
| Clene Inc. | 38.95 Million USD | -866.969% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -942.386% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -46.568% |
| GeoVax Labs, Inc. | 3.51 Million USD | -10600.475% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -97.96% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2992.401% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -89.915% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2988.562% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -682.865% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -612.787% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -1.836% |
| Evaxion Biotech A/S | 17.61 Million USD | -2037.899% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -134.044% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -145.874% |
| Trevena, Inc. | 48.26 Million USD | -680.415% |
| Surrozen, Inc. | 8.14 Million USD | -4524.236% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1644.126% |
| Cingulate Inc. | 10.36 Million USD | -3535.256% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -13596.145% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -909.986% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -10401.656% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -2764.213% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -18.74% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1415.731% |
| Clearmind Medicine Inc. | 3.61 Million USD | -10333.329% |
| Kronos Bio, Inc. | 54.2 Million USD | -594.902% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -700.638% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1554.87% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1776.558% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1560.948% |
| ImmunityBio, Inc. | 1.09 Billion USD | 65.458% |
| Korro Bio, Inc. | 51.75 Million USD | -627.786% |
| Kineta, Inc. | 7.22 Million USD | -5115.231% |
| BioVie Inc. | 9.7 Million USD | -3782.075% |
| Codexis, Inc. | 49.94 Million USD | -654.102% |
| Celularity Inc. | 102.92 Million USD | -265.926% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -291.331% |
| Celcuity Inc. | 51.45 Million USD | -632.057% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -109010.819% |
| Cibus, Inc. | 206.11 Million USD | -82.733% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -786.743% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -1329.986% |
| IN8bio, Inc. | 8.77 Million USD | -4193.707% |
| Kodiak Sciences Inc. | 213.59 Million USD | -76.339% |
| Annexon, Inc. | 47.11 Million USD | -699.363% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -320.639% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -290.823% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -2651.435% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 85.533% |
| Eyenovia, Inc. | 19.78 Million USD | -1804.139% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -112.69% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -4803.58% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1462.903% |
| Arcellx, Inc. | 339.75 Million USD | -10.859% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -3065.608% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -53.394% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -3838.555% |
| Moolec Science SA | 13.94 Million USD | -2600.856% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -772.831% |
| Geron Corporation | 146.12 Million USD | -157.751% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -645.357% |
| Royalty Pharma plc | 6.29 Billion USD | 94.019% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -846.913% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -127833.534% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -15208.977% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -99.118% |
| Humacyte, Inc. | 114.67 Million USD | -228.439% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1196.492% |
| 89bio, Inc. | 59.96 Million USD | -528.127% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1323.285% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -31391.973% |
| Genelux Corporation | 8.42 Million USD | -4373.207% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -5393.641% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -176.296% |
| Notable Labs, Ltd. | 4.42 Million USD | -8407.883% |
| Liquidia Corporation | 73.13 Million USD | -414.977% |
| Mustang Bio, Inc. | 17.61 Million USD | -2037.715% |
| Immunovant, Inc. | 48.95 Million USD | -669.368% |
| Quantum-Si incorporated | 26.63 Million USD | -1314.307% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -881.278% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -12038.06% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -409.936% |
| Acasti Pharma Inc. | 11.55 Million USD | -3159.012% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1565.997% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -13755.326% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -921.352% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -27536.659% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -6078.543% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1416.585% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1524.586% |
| PepGen Inc. | 34.63 Million USD | -987.592% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -3001.482% |
| United Therapeutics Corporation | 1.18 Billion USD | 68.14% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -5292.955% |
| Solid Biosciences Inc. | 38.45 Million USD | -879.365% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -4301.49% |
| Immuneering Corporation | 12 Million USD | -3036.516% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -119904.588% |
| Silo Pharma, Inc. | 1.56 Million USD | -23901.223% |
| Belite Bio, Inc | 4.21 Million USD | -8844.289% |
| XOMA Corporation | 145.58 Million USD | -158.72% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -15412.521% |
| Bionomics Limited | 10.15 Million USD | -3607.593% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1652.566% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1543.8% |
| uniQure N.V. | 624.01 Million USD | 39.642% |
| Cassava Sciences, Inc. | 14.19 Million USD | -2553.357% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -208334.928% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -121.316% |
| Forte Biosciences, Inc. | 3.66 Million USD | -10173.977% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -144438.976% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -5482.392% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -4803.58% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2066.738% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -3464.005% |
| Altimmune, Inc. | 16.54 Million USD | -2177.033% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 39.025% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1543.8% |
| Compugen Ltd. | 55.77 Million USD | -575.292% |
| Peak Bio, Inc. | 20.75 Million USD | -1714.858% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -240.968% |
| Benitec Biopharma Inc. | 4.96 Million USD | -7490.568% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -138.619% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -401.03% |
| Zura Bio Limited | 21.29 Million USD | -1668.946% |
| PolyPid Ltd. | 17.46 Million USD | -2056.194% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -235.096% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -401.03% |
| Instil Bio, Inc. | 99.8 Million USD | -277.395% |
| argenx SE | 444.95 Million USD | 15.352% |
| Immunome, Inc. | 28.65 Million USD | -1214.272% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -4417.74% |
| Verona Pharma plc | 58.84 Million USD | -540.105% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -2502.391% |
| Shattuck Labs, Inc. | 14.85 Million USD | -2434.787% |
| CervoMed Inc. | 2.59 Million USD | -14410.043% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -7627.616% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -2857.318% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -3475.168% |
| Moolec Science SA | 13.94 Million USD | -2600.856% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -15971.831% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -577.475% |
| AnaptysBio, Inc. | 364.28 Million USD | -3.392% |
| Design Therapeutics, Inc. | 11.95 Million USD | -3050.251% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -2869.442% |
| NeurAxis, Inc. | 1.91 Million USD | -19591.343% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -867.54% |
| Lumos Pharma, Inc. | 13.33 Million USD | -2724.901% |
| Achilles Therapeutics plc | 19.08 Million USD | -1873.301% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -2502.391% |
| 180 Life Sciences Corp. | 5.38 Million USD | -6891.45% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1496.762% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1554.87% |
| Nutriband Inc. | 1.07 Million USD | -34809.386% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1130.943% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -2495.576% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 6.138% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1059.868% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -2786.361% |
| Palisade Bio, Inc. | 2.73 Million USD | -13651.15% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -7070.074% |
| Beam Therapeutics Inc. | 478.38 Million USD | 21.268% |
| Neurogene Inc. | 36.54 Million USD | -930.518% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 5.354% |
| AEON Biopharma, Inc. | 159.88 Million USD | -135.566% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -690.439% |
| Sesen Bio, Inc. | 30.98 Million USD | -1115.608% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1350.807% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -4854.398% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -92.423% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -96.111% |
| Athira Pharma, Inc. | 30.05 Million USD | -1153.099% |
| Vaccinex, Inc. | 5.94 Million USD | -6238.674% |
| HCW Biologics Inc. | 15.05 Million USD | -2402.295% |
| XOMA Corporation | 145.58 Million USD | -158.72% |
| Nektar Therapeutics | 267.04 Million USD | -41.041% |
| Arvinas, Inc. | 644.6 Million USD | 41.569% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2023.957% |
| Merus N.V. | 102.15 Million USD | -268.713% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -157.358% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -295.967% |
| Rezolute, Inc. | 11.73 Million USD | -3109.852% |
| Clene Inc. | 38.95 Million USD | -866.969% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -13127.739% |
| BeyondSpring Inc. | 48.26 Million USD | -680.302% |
| Synlogic, Inc. | 32.89 Million USD | -1044.989% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -2477.458% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -22950.428% |
| Peak Bio, Inc. | 20.75 Million USD | -1714.858% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -493.523% |
| Krystal Biotech, Inc. | 39.71 Million USD | -848.391% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -278.274% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -86939.836% |
| MannKind Corporation | 721.36 Million USD | 47.787% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1586.34% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -17955.801% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -267.135% |
| Gossamer Bio, Inc. | 249.14 Million USD | -51.173% |
| CohBar, Inc. | 1.03 Million USD | -36338.676% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -3423.66% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1877.341% |
| Legend Biotech Corporation | 589.93 Million USD | 36.155% |
| Mural Oncology plc | 37.92 Million USD | -893.05% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -183.968% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -16309.129% |
| Disc Medicine, Inc. | 22.87 Million USD | -1546.531% |
| Champions Oncology, Inc. | 28.03 Million USD | -1243.478% |
| REGENXBIO Inc. | 262.22 Million USD | -43.632% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -11111.805% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2904.978% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -2704.158% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1676.204% |
| Vaxart, Inc. | 34.02 Million USD | -1006.963% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1747.266% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1220.081% |
| Cellectis S.A. | 249.57 Million USD | -50.914% |
| Longeveron Inc. | 5.33 Million USD | -6957.223% |
| Repare Therapeutics Inc. | 41.81 Million USD | -800.653% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 84.341% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -523.913% |
| Revolution Medicines, Inc. | 262.39 Million USD | -43.54% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -17775.842% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -4266.381% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -3091.628% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -2582.076% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -17410.181% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 92.686% |
| Denali Therapeutics Inc. | 122.96 Million USD | -206.307% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -6668.215% |
| Veru Inc. | 32.81 Million USD | -1047.86% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -5383.244% |
| Cingulate Inc. | 10.36 Million USD | -3535.256% |
| Passage Bio, Inc. | 39.26 Million USD | -859.309% |
| Context Therapeutics Inc. | 4.19 Million USD | -8885.439% |
| Exicure, Inc. | 8.54 Million USD | -4305.708% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1176.413% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -3491.875% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1608.834% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -131.09% |
| Nuvalent, Inc. | 31.82 Million USD | -1083.559% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -5820.561% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -497.639% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1992.467% |
| OmniAb, Inc. | 87.4 Million USD | -330.943% |
| Anew Medical, Inc. | 8.24 Million USD | -4469.925% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -883.685% |
| Lipocine Inc. | 2.63 Million USD | -14212.2% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1333.633% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -836.646% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1313.733% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -337.175% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -6873.597% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -355.175% |
| Ocugen, Inc. | 23.98 Million USD | -1470.462% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -711.61% |
| Q32 Bio Inc. | 233.12 Million USD | -61.561% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -4054.467% |
| Alumis Inc. Common Stock | 53.5 Million USD | -603.981% |
| Equillium, Inc. | 27.95 Million USD | -1247.226% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -82.313% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -6593.912% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -6041.301% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -139.404% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -442.457% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -3676.182% |
| Dominari Holdings Inc. | 4.63 Million USD | -8026.084% |
| Edesa Biotech, Inc. | 1.84 Million USD | -20351.587% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1173.866% |
| Bio-Techne Corporation | 744.34 Million USD | 49.399% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -198.689% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -9.345% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -828.266% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1200.701% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -307.8% |
| Nkarta, Inc. | 105.6 Million USD | -256.67% |
| BioCardia, Inc. | 4.59 Million USD | -8105.752% |
| Iterum Therapeutics plc | 32.66 Million USD | -1053.157% |